{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T03:17:25Z","timestamp":1743045445417,"version":"3.40.3"},"publisher-location":"Cham","reference-count":77,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319997155"},{"type":"electronic","value":"9783319997162"}],"license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-319-99716-2_8","type":"book-chapter","created":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T16:33:57Z","timestamp":1546187637000},"page":"163-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NK-Cell Lymphomas"],"prefix":"10.1007","author":[{"given":"Dai","family":"Chihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Oki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"8_CR1","unstructured":"Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H et al (2008) In: Lyon F (ed) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer"},{"issue":"4","key":"8_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536\u2013545","journal-title":"Br J Haematol"},{"issue":"9","key":"8_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","volume":"34","author":"SV Adams","year":"2016","unstructured":"Adams SV, Newcomb PA, Shustov AR (2016) Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States. J Clin Oncol 34(9):963\u2013971","journal-title":"J Clin Oncol"},{"issue":"5","key":"8_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","volume":"21","author":"R Suzuki","year":"2010","unstructured":"Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H et al (2010) Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol 21(5):1032\u20131040","journal-title":"Ann Oncol"},{"issue":"4","key":"8_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH et al (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24(4):612\u2013618","journal-title":"J Clin Oncol"},{"key":"8_CR6","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The international non-Hodgkin\u2019s lymphoma prognostic factors project. N Engl J Med 329(14):987\u2013994 (1993)","DOI":"10.1056\/NEJM199309303291402"},{"issue":"17","key":"8_CR7","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I et al (2009) Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113(17):3931\u20133937","journal-title":"Blood"},{"issue":"3","key":"8_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1023\/A:1011144911781","volume":"12","author":"WS Kim","year":"2001","unstructured":"Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY et al (2001) CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma? Ann Oncol 12(3):349\u2013352","journal-title":"Ann Oncol"},{"issue":"12","key":"8_CR9","first-page":"1343","volume":"87","author":"SY Song","year":"2002","unstructured":"Song SY, Kim WS, Ko YH, Kim K, Lee MH, Park K (2002) Aggressive natural killer cell leukemia: clinical features and treatment outcome. Haematologica 87(12):1343\u20131345","journal-title":"Haematologica"},{"issue":"3","key":"8_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/gcc.20245","volume":"44","author":"Y Nakashima","year":"2005","unstructured":"Nakashima Y, Tagawa H, Suzuki R, Karnan S, Karube K, Ohshima K et al (2005) Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type. Genes Chromosom Cancer 44(3):247\u2013255","journal-title":"Genes Chromosom Cancer"},{"issue":"4","key":"8_CR11","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63373-1","volume":"165","author":"M Lima","year":"2004","unstructured":"Lima M, Almeida J, Montero AG, Teixeira Mdos A, Queiros ML, Santos AH et al (2004) Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56\u2213\u2009dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 165(4):1117\u20131127","journal-title":"Am J Pathol"},{"issue":"4","key":"8_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1046\/j.1365-2141.1999.01624.x","volume":"106","author":"GR Rabbani","year":"1999","unstructured":"Rabbani GR, Phyliky RL, Tefferi A (1999) A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 106(4):960\u2013966","journal-title":"Br J Haematol"},{"issue":"6","key":"8_CR13","first-page":"782","volume":"7","author":"K Oshimi","year":"1993","unstructured":"Oshimi K, Yamada O, Kaneko T, Nishinarita S, Iizuka Y, Urabe A et al (1993) Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 7(6):782\u2013788","journal-title":"Leukemia"},{"issue":"11","key":"8_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/01.pas.0000168510.54867.9a","volume":"29","author":"Q Huang","year":"2005","unstructured":"Huang Q, Chang KL, Gaal KK, Weiss LM (2005) An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder. Am J Surg Pathol 29(11):1540\u20131543","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"8_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/1097-0142(19890701)64:1<63::AID-CNCR2820640111>3.0.CO;2-#","volume":"64","author":"Y Ohno","year":"1989","unstructured":"Ohno Y, Amakawa R, Fukuhara S, Huang CR, Kamesaki H, Amano H et al (1989) Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality. Cancer 64(1):63\u201367","journal-title":"Cancer"},{"issue":"25","key":"8_CR16","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","volume":"116","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K et al (2010) Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116(25):5631\u20135637","journal-title":"Blood"},{"issue":"5","key":"8_CR17","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","volume":"117","author":"A Mansoor","year":"2011","unstructured":"Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011) NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood 117(5):1447\u20131452","journal-title":"Blood"},{"issue":"4","key":"8_CR18","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","volume":"87","author":"JF Emile","year":"1996","unstructured":"Emile JF, Boulland ML, Haioun C, Kanavaros P, Petrella T, Delfau-Larue MH et al (1996) CD5-CD56+\u2009T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87(4):1466\u20131473","journal-title":"Blood"},{"issue":"8","key":"8_CR19","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood.V83.8.2255.2255","volume":"83","author":"J Suzumiya","year":"1994","unstructured":"Suzumiya J, Takeshita M, Kimura N, Kikuchi M, Uchida T, Hisano S et al (1994) Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 83(8):2255\u20132260","journal-title":"Blood"},{"issue":"5","key":"8_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","volume":"31","author":"K Ohshima","year":"1997","unstructured":"Ohshima K, Suzumiya J, Shimazaki K, Kato A, Tanaka T, Kanda M et al (1997) Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology 31(5):444\u2013450","journal-title":"Histopathology"},{"issue":"2","key":"8_CR21","first-page":"699","volume":"149","author":"N Mori","year":"1996","unstructured":"Mori N, Yatabe Y, Oka K, Kinoshita T, Kobayashi T, Ono T et al (1996) Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. Am J Pathol 149(2):699\u2013705","journal-title":"Am J Pathol"},{"issue":"4","key":"8_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","volume":"98","author":"KF Wong","year":"1997","unstructured":"Wong KF, Chan JK, Kwong YL (1997) Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia. Br J Haematol 98(4):922\u2013926","journal-title":"Br J Haematol"},{"issue":"3","key":"8_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1365-2141.1997.752711.x","volume":"97","author":"HF Tien","year":"1997","unstructured":"Tien HF, Su IJ, Tang JL, Liu MC, Lee FY, Chen YC et al (1997) Clonal chromosomal abnormalities as direct evidence for clonality in nasal T\/natural killer cell lymphomas. Br J Haematol 97(3):621\u2013625","journal-title":"Br J Haematol"},{"issue":"12","key":"8_CR24","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y et al (2011) Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 118(12):3195\u20133204","journal-title":"Blood"},{"issue":"6","key":"8_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H et al (2009) Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 23(6):1139\u20131151","journal-title":"Leukemia"},{"issue":"4","key":"8_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.leu.2403262","volume":"18","author":"R Suzuki","year":"2004","unstructured":"Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S et al (2004) Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18(4):763\u2013770","journal-title":"Leukemia"},{"issue":"15","key":"8_CR27","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","volume":"18","author":"Y Ito","year":"2012","unstructured":"Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K et al (2012) Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clin Cancer Res 18(15):4183\u20134190 An Official Journal of the American Association for Cancer Research","journal-title":"Clin Cancer Res"},{"issue":"23","key":"8_CR28","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y et al (2011) Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood 118(23):6018\u20136022","journal-title":"Blood"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/emm.2014.105","volume":"47","author":"Q Cai","year":"2015","unstructured":"Cai Q, Chen K, Young KH (2015) Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorders. Exp Mol Med 47:e133","journal-title":"Exp Mol Med"},{"issue":"1","key":"8_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2141.2001.02885.x","volume":"114","author":"C Trambas","year":"2001","unstructured":"Trambas C, Wang Z, Cianfriglia M, Woods G (2001) Evidence that natural killer cells express mini P-glycoproteins but not classic 170\u00a0kDa P-glycoprotein. Br J Haematol 114(1):177\u2013184","journal-title":"Br J Haematol"},{"issue":"2","key":"8_CR31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","volume":"93","author":"M Egashira","year":"1999","unstructured":"Egashira M, Kawamata N, Sugimoto K, Kaneko T, Oshimi K (1999) P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 93(2):599\u2013606","journal-title":"Blood"},{"issue":"11","key":"8_CR32","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","volume":"76","author":"M Yamaguchi","year":"1995","unstructured":"Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T et al (1995) Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells. Cancer 76(11):2351\u20132356","journal-title":"Cancer"},{"issue":"1","key":"8_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","volume":"24","author":"YX Li","year":"2006","unstructured":"Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW et al (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma. J Clin Oncol 24(1):181\u2013189","journal-title":"J Clin Oncol"},{"issue":"4","key":"8_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/annonc\/mdh143","volume":"15","author":"JY You","year":"2004","unstructured":"You JY, Chi KH, Yang MH, Chen CC, Ho CH, Chau WK et al (2004) Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 15(4):618\u2013625","journal-title":"Ann Oncol"},{"issue":"1","key":"8_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamaoncol.2016.5094","volume":"3","author":"Y Yang","year":"2017","unstructured":"Yang Y, Cao JZ, Lan SM, Wu JX, Wu T, Zhu SY et al (2017) Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type natural killer\/T-cell lymphoma. JAMA Oncol 3(1):83\u201391","journal-title":"JAMA Oncol"},{"issue":"1","key":"8_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","volume":"18","author":"GE Kim","year":"2000","unstructured":"Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR et al (2000) Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 18(1):54\u201363","journal-title":"J Clin Oncol"},{"issue":"1","key":"8_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","volume":"16","author":"MM Cheung","year":"1998","unstructured":"Cheung MM, Chan JK, Lau WH, Foo W, Chan PT, Ng CS et al (1998) Primary non-Hodgkin\u2019s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16(1):70\u201377","journal-title":"J Clin Oncol"},{"issue":"33","key":"8_CR38","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y et al (2009) Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan clinical oncology group study JCOG0211. J Clin Oncol 27(33):5594\u20135600","journal-title":"J Clin Oncol"},{"issue":"32","key":"8_CR39","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1200\/JCO.2012.45.6541","volume":"30","author":"M Yamaguchi","year":"2012","unstructured":"Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y et al (2012) Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211. J Clin Oncol 30(32):4044\u20134046","journal-title":"J Clin Oncol"},{"issue":"35","key":"8_CR40","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","volume":"27","author":"SJ Kim","year":"2009","unstructured":"Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J et al (2009) Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: consortium for improving survival of lymphoma study. J Clin Oncol 27(35):6027\u20136032","journal-title":"J Clin Oncol"},{"issue":"11","key":"8_CR41","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00277-014-2137-6","volume":"93","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS et al (2014) Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK\/T cell lymphoma: CISL08-01 phase II study. Ann Hematol 93(11):1895\u20131901","journal-title":"Ann Hematol"},{"issue":"51","key":"8_CR42","doi-asserted-by":"publisher","first-page":"85584","DOI":"10.18632\/oncotarget.11319","volume":"7","author":"DH Yoon","year":"2016","unstructured":"Yoon DH, Kim SJ, Jeong SH, Shin DY, Bae SH, Hong J et al (2016) Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I\/II extranodal NK\/T-cell lymphoma, nasal type (CISL-1008). Oncotarget 7(51):85584\u201385591","journal-title":"Oncotarget"},{"issue":"2","key":"8_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/cncr.27752","volume":"119","author":"L Wang","year":"2013","unstructured":"Wang L, Wang ZH, Chen XQ, Li YJ, Wang KF, Xia YF et al (2013) First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma. Cancer 119(2):348\u2013355","journal-title":"Cancer"},{"issue":"13","key":"8_CR44","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1002\/cncr.26629","volume":"118","author":"M Jiang","year":"2012","unstructured":"Jiang M, Zhang H, Jiang Y, Yang Q, Xie L, Liu W et al (2012) Phase 2 trial of \u201csandwich\u201d L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer\/T-cell lymphoma. Cancer 118(13):3294\u20133301","journal-title":"Cancer"},{"issue":"33","key":"8_CR45","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C et al (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 29(33):4410\u20134416","journal-title":"J Clin Oncol"},{"issue":"15","key":"8_CR46","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","volume":"120","author":"YL Kwong","year":"2012","unstructured":"Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T, Tse E et al (2012) SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 120(15):2973\u20132980","journal-title":"Blood"},{"issue":"4","key":"8_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00277-015-2581-y","volume":"95","author":"SM Kim","year":"2016","unstructured":"Kim SM, Park S, Oh DR, Ahn YC, Ko YH, Kim SJ et al (2016) Extra-nodal natural killer\/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability. Ann Hematol 95(4):581\u2013591","journal-title":"Ann Hematol"},{"issue":"9","key":"8_CR48","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1200\/JCO.2011.40.7098","volume":"30","author":"Alexandre Chan","year":"2012","unstructured":"Chan A, Tang T, Ng T, Shih V, Tay K, Tao M et al (2012) To SMILE or not: supportive care matters. J Clin Oncol 30(9):1015\u20131016. Author reply 6\u20137","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"8_CR49","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","volume":"117","author":"A Jaccard","year":"2011","unstructured":"Jaccard A, Gachard N, Marin B, Rogez S, Audrain M, Suarez F et al (2011) Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study. Blood 117(6):1834\u20131839","journal-title":"Blood"},{"issue":"11","key":"8_CR50","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s00277-014-2136-7","volume":"93","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Li X, Chen C, Li X, Zhang L, Li L et al (2014) Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed\/refractory extranodal NK\/T cell lymphoma: a retrospective study of 17 patients. Ann Hematol 93(11):1889\u20131894","journal-title":"Ann Hematol"},{"issue":"21","key":"8_CR51","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1158\/1078-0432.CCR-16-0153","volume":"22","author":"X Li","year":"2016","unstructured":"Li X, Cui Y, Sun Z, Zhang L, Li L, Wang X et al (2016) DDGP versus SMILE in newly diagnosed advanced natural killer\/T-cell lymphoma: a randomized controlled, multicenter, open-label study in China. Clin Cancer Res 22(21):5223\u20135228 An Official Journal of the American Association for Cancer Research","journal-title":"Clin Cancer Res"},{"issue":"16","key":"8_CR52","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-16-1076","volume":"22","author":"VG Gupta","year":"2016","unstructured":"Gupta VG, Gogia A (2016) DDGP versus SMILE in NK\/T-cell lymphoma-letter. Clin Cancer Res 22(16):4271 An Official Journal of the American Association for Cancer Research","journal-title":"Clin Cancer Res"},{"issue":"3","key":"8_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/10428194.2012.720374","volume":"54","author":"H Takahashi","year":"2013","unstructured":"Takahashi H, Sakai R, Hattori Y, Ohshima R, Kuwabara H, Hagihara M et al (2013) Successful disease control with L-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure. Leuk Lymphoma 54(3):662\u2013664","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"8_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","volume":"92","author":"R Suzuki","year":"2010","unstructured":"Suzuki R (2010) Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia. Int J Hematol 92(5):697\u2013701","journal-title":"Int J Hematol"},{"issue":"3","key":"8_CR55","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H et al (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol 17(3):389\u2013400","journal-title":"Lancet Oncol"},{"issue":"1","key":"8_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.2016.68.1619","volume":"35","author":"M Yamaguchi","year":"2017","unstructured":"Yamaguchi M, Suzuki R, Oguchi M, Asano N, Amaki J, Akiba T et al (2017) Treatments and outcomes of patients with extranodal natural killer\/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan. J Clin Oncol 35(1):32\u201339","journal-title":"J Clin Oncol"},{"issue":"1","key":"8_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, Chim CS, Kwong YL (2004) Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104(1):243\u2013249","journal-title":"Blood"},{"issue":"1","key":"8_CR58","first-page":"29","volume":"8","author":"KI Lei","year":"2002","unstructured":"Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM (2002) Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer\/T-cell lymphoma. Clin Cancer Res 8(1):29\u201334 An Official Journal of the American Association for Cancer Research","journal-title":"Clin Cancer Res"},{"issue":"10","key":"8_CR59","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","volume":"120","author":"ZY Wang","year":"2012","unstructured":"Wang ZY, Liu QF, Wang H, Jin J, Wang WH, Wang SL et al (2012) Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy. Blood 120(10):2003\u20132010","journal-title":"Blood"},{"issue":"30","key":"8_CR60","doi-asserted-by":"crossref","first-page":"30317","DOI":"10.18632\/oncotarget.4505","volume":"6","author":"L Wang","year":"2015","unstructured":"Wang L, Wang H, Wang JH, Xia ZJ, Lu Y, Huang HQ et al (2015) Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK\/T cell lymphoma in the era of asparaginase. Oncotarget 6(30):30317\u201330326","journal-title":"Oncotarget"},{"issue":"4","key":"8_CR61","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","volume":"37","author":"R Suzuki","year":"2006","unstructured":"Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka JI, Sakai C et al (2006) Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transpl 37(4):425\u2013431","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"8_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","volume":"37","author":"HJ Kim","year":"2006","unstructured":"Kim HJ, Bang SM, Lee J, Kwon HC, Suh C, Kim HJ et al (2006) High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transpl 37(9):819\u2013824","journal-title":"Bone Marrow Transpl"},{"issue":"11","key":"8_CR63","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/annonc\/mdg458","volume":"14","author":"WY Au","year":"2003","unstructured":"Au WY, Lie AK, Liang R, Kwong YL, Yau CC, Cheung MM et al (2003) Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report on its value. Ann Oncol 14(11):1673\u20131676","journal-title":"Ann Oncol"},{"issue":"12","key":"8_CR64","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.bbmt.2008.09.014","volume":"14","author":"J Lee","year":"2008","unstructured":"Lee J, Au WY, Park MJ, Suzumiya J, Nakamura S, Kameoka J et al (2008) Autologous hematopoietic stem cell transplantation in extranodal natural killer\/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transpl 14(12):1356\u20131364","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"8_CR65","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.bbmt.2015.05.003","volume":"21","author":"HY Yhim","year":"2015","unstructured":"Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y et al (2015) Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer\/T cell lymphoma. Biol Blood Marrow Transpl 21(9):1597\u20131604","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"8_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05651.x","volume":"130","author":"N Murashige","year":"2005","unstructured":"Murashige N, Kami M, Kishi Y, Kim SW, Takeuchi M, Matsue K et al (2005) Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 130(4):561\u2013567","journal-title":"Br J Haematol"},{"issue":"7","key":"8_CR67","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/bmt.2014.65","volume":"49","author":"E Tse","year":"2014","unstructured":"Tse E, Chan TS, Koh LP, Chng WJ, Kim WS, Tang T et al (2014) Allogeneic haematopoietic SCT for natural killer\/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group. Bone Marrow Transpl 49(7):902\u2013906","journal-title":"Bone Marrow Transpl"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-016-0271-4","volume":"9","author":"KS Jung","year":"2016","unstructured":"Jung KS, Cho SH, Kim SJ, Ko YH, Kang ES, Kim WS (2016) L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia. J Hematol Oncol 9:41","journal-title":"J Hematol Oncol"},{"key":"8_CR69","doi-asserted-by":"crossref","unstructured":"Hamadani M, Kanate AS, DiGilio A, Ahn KW, Smith SM, Lee JW et al (2017) Allogeneic hematopoietic cell transplantation for aggressive NK cell leukemia. Biol Blood Marrow Transpl. A Center for International Blood and Marrow Transplant Research Analysis","DOI":"10.1016\/j.bbmt.2017.01.082"},{"issue":"5","key":"8_CR70","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1182\/blood-2002-05-1514","volume":"101","author":"S Gottschalk","year":"2003","unstructured":"Gottschalk S, Edwards OL, Sili U, Huls MH, Goltsova T, Davis AR et al (2003) Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Blood 101(5):1905\u20131912","journal-title":"Blood"},{"issue":"8","key":"8_CR71","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","volume":"32","author":"CM Bollard","year":"2014","unstructured":"Bollard CM, Gottschalk S, Torrano V, Diouf O, Ku S, Hazrat Y et al (2014) Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol 32(8):798\u2013808","journal-title":"J Clin Oncol"},{"key":"8_CR72","doi-asserted-by":"crossref","unstructured":"Armand P, Shipp MA, Ribrag V, Michot JM, Zinzani PL, Kuruvilla J et al (2016) Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure. J Clin Oncol","DOI":"10.1200\/JCO.2016.67.3467"},{"issue":"4","key":"8_CR73","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1411087","volume":"372","author":"SM Ansell","year":"2015","unstructured":"Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M et al (2015) PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma. N Engl J Med 372(4):311\u2013319","journal-title":"N Engl J Med"},{"key":"8_CR74","doi-asserted-by":"crossref","unstructured":"Kwong YL, Chan TS, Tan D, Kim SJ, Poon LM, Mow B et al (2017) PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing L-asparaginase. Blood","DOI":"10.1182\/blood-2016-12-756841"},{"issue":"10027","key":"8_CR75","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(15)01120-4","volume":"387","author":"S Lonial","year":"2016","unstructured":"Lonial S, Weiss BM, Usmani SZ, Singhal S, Chari A, Bahlis NJ et al (2016) Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Lancet 387(10027):1551\u20131560","journal-title":"Lancet"},{"issue":"15","key":"8_CR76","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJMc1605684","volume":"375","author":"P Hari","year":"2016","unstructured":"Hari P, Raj RV, Olteanu H (2016) Targeting CD38 in refractory extranodal natural killer cell-T-cell lymphoma. N Engl J Med 375(15):1501\u20131502","journal-title":"N Engl J Med"},{"issue":"3","key":"8_CR77","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdv596","volume":"27","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Kim JH, Ki CS, Ko YH, Kim JS, Kim WS (2016) Epstein-Barr virus reactivation in extranodal natural killer\/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin. Ann Oncol 27(3):508\u2013513","journal-title":"Ann Oncol"}],"container-title":["Cancer Treatment and Research","T-Cell and NK-Cell Lymphomas"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-99716-2_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T09:05:53Z","timestamp":1662714353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-99716-2_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"ISBN":["9783319997155","9783319997162"],"references-count":77,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-99716-2_8","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"type":"print","value":"0927-3042"},{"type":"electronic","value":"2509-8497"}],"subject":[],"published":{"date-parts":[[2018,12,31]]},"assertion":[{"value":"31 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}